# Breakthrough in Alzheimer's Treatment Shows 40% Slowdown in Progression

**Category:** Health
**Source:** [https://www.nature.com/articles/s41586-025-00012-3](https://www.nature.com/articles/s41586-025-00012-3)
**Publisher:** Nature
**Published:** 2025-12-31
**Scraped (UTC):** 2026-01-01T13:47:20+00:00

## Summary
A phase 3 trial of a novel monoclonal antibody has demonstrated a 40% reduction in cognitive decline for early-stage Alzheimer's patients, marking a potential game-changer after decades of failures.

## Full Article
*(Article text could not be extracted. Visit source link above.)*

---

*Content scraped from public sources with attribution. Users assume all risk.*  
*Auto-generated by [Perplexity News Tracker](https://github.com/myidkd1-coder/perplexity-news-tracker)*